Telomere repeats are added onto chromosome ends by telomerase, consisting of two main core components: a catalytic protein subunit (telomerase reverse trancriptase, TERT), and an RNA subunit (telomerase RNA, TR). Here, we report for the first time evidence that HMGB1 (a chromatin-associated protein in mammals, acting as a DNA chaperone in transcription, replication, recombination, and repair) can modulate cellular activity of mammalian telomerase. Knockout of the HMGB1 gene (HMGB1 KO) in mouse embryonic fibroblasts (MEFs) results in chromosomal abnormalities, enhanced colocalization of γ-H2AX foci at telomeres, and a moderate shortening of telomere lengths. HMGB1 KO MEFs also exhibit significantly (>5-fold) lower telomerase activity than the wild-type MEFs. Correspondingly, enhanced telomerase activity is observed upon overexpression of HMGB1 in MEFs. HMGB1 physically interacts with both TERT and TR, as well as with active telomerase complex in vitro. However, direct interaction of HMGB1 with telomerase is most likely not accountable for the observed higher telomerase activity in HMGB1-containing cells, as revealed from the inability of purified HMGB1 protein to stimulate telomerase activity in vitro. While no transcriptional silencing of TERT is observed in HMGB1 KO MEFs, levels of TR are diminished (~3-fold), providing possible explanation for the observed lower telomerase activity in HMGB1 KO cells. Interestingly, knockout of the HMGB2 gene elevates telomerase activity (~3-fold) in MEFs, suggesting that the two closely related proteins of the HMGB family, HMGB1 and HMGB2, have opposite effects on telomerase activity in the cell. The ability of HMGB1 to modulate cellular activity of telomerase and to maintain telomere integrity can help to understand some aspects of the protein involvement in chromosome stability and cancer.

Academy of Sciences of the Czech Republic Institute of Biophysics Brno Czech Republic

See more in PubMed

J Cell Biol. 1997 Apr 7;137(1):19-26 PubMed

Genes Dev. 2005 Sep 15;19(18):2100-10 PubMed

Oncogene. 2002 Feb 21;21(9):1434-42 PubMed

Methods Cell Biol. 2001;64:69-96 PubMed

Development. 2001 Apr;128(8):1265-73 PubMed

Mol Gen Genet. 1995 Jun 10;247(5):633-8 PubMed

J Biol Chem. 2004 Dec 31;279(53):55401-10 PubMed

Mol Pharmacol. 2008 Jan;73(1):260-9 PubMed

Curr Biol. 2005 Jan 11;15(1):68-72 PubMed

Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):101-13 PubMed

Curr Protein Pept Sci. 2011 Mar;12(2):105-11 PubMed

Curr Biol. 2003 Sep 2;13(17):1549-56 PubMed

J Biol Chem. 2002 Mar 1;277(9):7157-64 PubMed

J Biol Chem. 2009 Nov 6;284(45):30871-80 PubMed

Curr Biol. 2000 Jul 27-Aug 10;10(15):886-95 PubMed

FEBS Lett. 2003 Nov 20;554(3):455-61 PubMed

Biol Cell. 2009 Jul;101(7):375-92, 1 p following 392 PubMed

Biotechniques. 2003 Nov;35(5):912-4 PubMed

Eur J Biochem. 2000 Jul;267(13):4088-97 PubMed

Nature. 2000 May 18;405(6784):354-60 PubMed

J Mol Biol. 2005 Nov 4;353(4):822-37 PubMed

Nucleic Acids Res. 2000 Nov 15;28(22):4474-8 PubMed

Mech Ageing Dev. 2008 Jan-Feb;129(1-2):91-8 PubMed

Trends Biochem Sci. 2001 Mar;26(3):167-74 PubMed

J Biol Chem. 1998 Apr 24;273(17):10355-61 PubMed

Biochem J. 2006 Aug 1;397(3):399-406 PubMed

Cell. 2009 Jan 9;136(1):175-86 PubMed

Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):119-30 PubMed

Philos Trans R Soc Lond B Biol Sci. 2002 Apr 29;357(1420):545-62 PubMed

Mol Cell. 2005 Apr 1;18(1):109-21 PubMed

DNA Repair (Amst). 2004 Aug-Sep;3(8-9):959-67 PubMed

Nat Genet. 1999 Jul;22(3):276-80 PubMed

Biochimie. 2008 Jan;90(1):13-23 PubMed

Genes Dev. 1999 Apr 1;13(7):817-26 PubMed

DNA Repair (Amst). 2006 Sep 8;5(9-10):1082-92 PubMed

Biochem Biophys Res Commun. 1998 May 8;246(1):137-41 PubMed

Nat Protoc. 2006;1(3):1583-90 PubMed

Curr Opin Genet Dev. 2003 Apr;13(2):170-8 PubMed

Blood Cells Mol Dis. 2000 Oct;26(5):534-9 PubMed

Nucleic Acids Res. 2007;35(15):5001-13 PubMed

Nonhistone Proteins HMGB1 and HMGB2 Differentially Modulate the Response of Human Embryonic Stem Cells and the Progenitor Cells to the Anticancer Drug Etoposide